bicalutamide has been researched along with choline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holzapfel, K; Krause, BJ; Müller, SA; Seidl, C; Senekowitsch-Schmidtke, R; Treiber, U | 1 |
| Castellucci, P; Celli, M; Fanti, S; Fuccio, C; Malizia, C; Martorana, G; Marzola, MC; Pettinato, V; Profitos, MB; Rubello, D; Schiavina, R | 1 |
2 other study(ies) available for bicalutamide and choline
| Article | Year |
|---|---|
Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Choline; Diffusion; Docetaxel; Hemicholinium 3; Humans; Male; Nitriles; Organic Cation Transport Proteins; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Taxoids; Tosyl Compounds; Tritium | 2009 |
Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androgens; Anilides; Biological Transport; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Nitriles; Positron-Emission Tomography; Prostatic Neoplasms; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Tosyl Compounds | 2011 |